Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

5.64
+0.03000.53%
Volume:104.20K
Turnover:591.20K
Market Cap:773.49M
PE:-1.47
High:5.78
Open:5.67
Low:5.63
Close:5.61
Loading ...
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 04, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Sep 20, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities